In conclusion, high consumption of glycolysis and glutaminolysis in immune-resistant phenotype tumors, such as NSCLC with LKB1 and/or KEAP1 inactivation, not only contribute to tumor aggressiveness but also impede intratumor T-cell function. Here, STK11 is linked to neoplasm.